RAB44: Potential Drug Target Or Biomarker for Cancer (G401258)

Target Name: RAB44

NCBI ID: G401258

RAB44

RAB44: Potential Drug Target Or Biomarker for Cancer

RAB44 (RASD3) is a protein that is expressed in many tissues throughout the body. It is a member of the RAS/MAPK signaling pathway, which is a critical pathway that regulates various cellular processes including cell growth, differentiation, and survival. The RAS /MAPK signaling pathway is also known as the MAPK/ERK signaling pathway, as it involves the protein kinase (MAPK) and its downstream target, the protein kinase-3 (ERK).

The RAB44 protein is composed of 180 amino acid residues and has a calculated molecular weight of 19.3 kDa. It is expressed in many tissues, including muscle, heart, liver, and brain. It is also highly expressed in cancer tissues, which suggests that it may be a potential drug target or biomarker for cancer.

The RAB44 protein is involved in various cellular processes, including cell signaling, cell adhesion, and cell survival. It is a critical regulator of the RAS/MAPK signaling pathway, which is responsible for promoting cell growth, differentiation, and survival. plays a crucial role in regulating the growth and differentiation of various tissues, including muscle, heart, liver, and brain.

The RAB44 protein is also involved in cell adhesion. It is a critical regulator of cell-cell adhesion, which is essential for the development and maintenance of tissues and organs. The RAB44 protein helps to regulate the formation of tight junctions, which are a type of cell-cell adhesion that is critical for the development of tissues such as the placenta and the gut lining.

The RAB44 protein is also involved in cell survival. It is a critical regulator of cell survival, as it helps to prevent cell death. The RAB44 protein plays a crucial role in regulating the production of reactive oxygen species (ROS), which can damage cellular components and contribute to cell death.

The RAB44 protein is a potential drug target or biomarker for various diseases, including cancer. The RAS/MAPK signaling pathway is a known target for many anti-cancer drugs, including inhibitors of the MAPK pathway. The RAB44 protein is also a good candidate for biomarker research in cancer, as its expression is highly correlated with the development and progression of many types of cancer.

In conclusion, RAB44 (RASD3) is a protein that is involved in various cellular processes, including cell signaling, cell adhesion, and cell survival. It is a critical regulator of the RAS/MAPK signaling pathway and is highly expressed in cancer tissues. The RAB44 protein is a potential drug target or biomarker for various diseases, including cancer. Further research is needed to fully understand its role in cellular processes and its potential as a drug or biomarker.

Protein Name: RAB44, Member RAS Oncogene Family

The "RAB44 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RAB44 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets